Evidence map›Paper›PMID 35684466›Full record

ArticleMolecules (Basel, Switzerland)2022

Cholesterol Dependent Activity of the Adenosine A

Claire McGraw, Kirsten Swonger Koretz, Daniel Oseid, Edward Lyman, Anne Skaja Robinson

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Journal of medicinal chemistry · 2024
    Review
  7. Lipid regulation of the glucagon receptor family.The Journal of endocrinology · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Claire McGrawDepartment of Chemical and Biomolecular Engineering, Tulane University, New Orleans, LA 70118, USA.
Kirsten Swonger KoretzDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0002-0421-3869
Daniel OseidDepartment of Chemical and Biomolecular Engineering, Tulane University, New Orleans, LA 70118, USA.
Edward LymanDepartment of Physics and Astronomy, University of Delaware, Newark, DE 19711, USA.
Anne Skaja RobinsonDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0001-7235-1481
Carnegie Mellon University · USTulane University · USUniversity of Delaware · US

Funding

Effects of lipidomic diversity on GPCRR01GM120351 · NIGMS · UNIVERSITY OF DELAWARE · PI LYMAN, EDWARD RAY · 2017 to 2021
$1.6M
Louisiana Board of Regents LEQSF (2012-17)-GF-16NIGMS NIH HHS R01 GM120351NIH HHS R01 GM120351-01A1
6 · The paper itself

Abstract

backgroundMembrane cholesterol dysregulation has been shown to alter the activity of the adenosine A

methodsHere, we use experimental methods to determine whether a specific interaction between amino acid side chains in the cholesterol consensus motif (CCM) of full length, wild-type human A RESULTS AND

conclusionsOur data, taken with previously published studies, support a model of receptor state-dependent binding between cholesterol and the CCM, whereby cholesterol facilitates both G protein coupling and downstream signaling of A

Indexed as

AdenosineReceptor, Adenosine A2AAdenosine A2 Receptor AgonistsCarrier ProteinsCholesterolCyclic AMPHumansAdenosineAdenosine A2 Receptor AgonistsCarrier ProteinsCholesterolCyclic AMPReceptor, Adenosine A2ACGS21680cholesterolGαsmethyl β cyclodextrinradioligand bindingsurface plasmon resonanceZM241386

Identifiers

PMID35684466
PMCPMC9182133
OpenAlexW4281614963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.